/
Azacitidine use in post transplant relapse of MDS and AML Azacitidine use in post transplant relapse of MDS and AML

Azacitidine use in post transplant relapse of MDS and AML - PowerPoint Presentation

test
test . @test
Follow
352 views
Uploaded On 2018-10-30

Azacitidine use in post transplant relapse of MDS and AML - PPT Presentation

Jennifer Vaughn MD Bart Scott MD Myelodysplastic syndromes Clonal hematopoetic disorder in which ineffective or dysplastic cell production leads to peripheral cytopenias Variable risk of transformation to acute myeloid leukemia ID: 703583

survival patients relapse azacitidine patients survival azacitidine relapse days therapy mds time transplant persistent aml median post cell months

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Azacitidine use in post transplant relap..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript